ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatien... (ether in this manner. Thorough ...)

HOME >> MEDICINE >> TECHNOLOGY

ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services

Date:5/8/2009

ether in this manner."

"Thorough assessments which lead to individualized treatment plans as well as discharge coordination are areas that ValueOptions(R) advocates," said Hal Levine, D.O., chief medical officer for ValueOptions(R). "We routinely encourage hospitals to minimize their use of seclusion, restraint and polypharmacy. The Joint Commission's measures will help all parties involved to provide optimal services when treating members."

More information regarding The Joint Commission's HBIPS performance measures can be found on The Joint Commission's Web site.

About ValueOptions(R), Inc.

ValueOptions(R), Inc., the nation's largest independent behavioral health and wellness company, provides services to more than 23 million individuals through a variety of contracts with state and county agencies and, additionally, with health plans and employers. ValueOptions(R) is a national behavioral health and wellness company that specializes in management for all behavioral health issues and promotes health and wellness through innovative programs. ValueOptions(R) mission is to improve the health and wellness for the people it serves.

www.ValueOptions.com

SOURCE ValueOptions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. First Human Study to Show Sun Chlorella A Supports Heart Health
2. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
3. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
4. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
5. APTA Supports Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
6. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
7. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
8. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
9. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
10. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
11. Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients

Post Your Comments:

(Date:12/2/2009)...BOTT PARK, Ill., Dec. 2 ...erizing a vast array of microorganisms has been na...entist magazine. A panel of expert judges evalua...determine the year,s top innovations, with the win...and online at www.the-scien t ist.com/top10inn...

(Date:12/2/2009)...W YORK, Dec. 2 With the addition o..., led by Neil H. Ekblom, LeClairRyan,s medical mal...d its reach in the New York market. Mr. Ekblom, a ...e in defending ophthalmology-related malpractice c... group of medical malpractice defense attorneys lo...

(Date:12/2/2009)...NTENNIAL, Colo., Dec. 2 AlloSource... of skin, bone and soft tissue allografts for use ...cessor of live cellular bone growth substitutes, t...ymbol of hope as a float rider aboard the annual D... of Roses Parade®. Manuel Salazar, a 29-year...

Breaking Medicine Technology:Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2 Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 2 Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 3 AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2 AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3 Stuff of stink bombs investigated for role in pregnancy 9288 1 Wolf reintroduction proposed in Scottish Highland test case 9286 1 Wolf reintroduction proposed in Scottish Highland test case 9286 2 Wolf reintroduction proposed in Scottish Highland test case 9286 3 Treating Kids 26apos 3B Summertime Bumps Bruises and Injuries with The Healthcare Scoop 52132 1 Treating Kids 26apos 3B Summertime Bumps Bruises and Injuries with The Healthcare Scoop 52132 2 Treating Kids 26apos 3B Summertime Bumps Bruises and Injuries with The Healthcare Scoop 52132 3

[0] Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist [0] Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan [0] AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float

...y Systems and Specific Molecular Structures Needed...ccess, LONDON, April 7, 2008 Silence Therapeutic...echnology company, today,comments on two recent jo...ependent angiogenesis suppression by siRNA via TLR...lls(2) "Immune Activation by,siRNA/Liposome Comple...

...dy Reinforces Anti-Inflammatory Properties of Red ...swire/- A new study shows tart cherries,one of tod...mmation,potentially lowering the risk of type 2 di...study was presented by University of Michigan rese...eeting. As science continues to,reveal inflammatio...

Other Medicine Technology:Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2 Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3 Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4 Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 2 Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease 3

Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach Tart Cherries May Reduce Inflammation, Lower Risk for Type 2 Diabetes & Heart Disease

(Date:12/3/2009)... the life-long focus of his research and now, Pete...prehensive Cancer Center at Georgetown University ...al-edition of Cancer Epidemiology, Biomarkers & P...ctices in tobacco science from researchers the wor...al of the American Association for Cancer Research...

(Date:12/2/2009)...Newswire/ -- The American Association of Poison Co...onal Poison Center in Minneapolis, Minnesota as an...one for the center. The designation by the AAPCC ...8 accredited poison centers in the United States. ...ment. It means we have met the national standards ...

(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Renal Disease Treatments: Products and Therapie...al-Disease-Treatments-Products-and-Therapies.html ...nd services, providing data for 2008 and estimates...ound annual growth rates (CAGRs) from 2009 to 2014...

(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Point of Care Diagnostics ,, http://www.re...html ,, Provides a complete review and analysi...,, Includes market forecasts through 2014 for t...eral regulation of POC testing ,, Analyzes mar...

(Date:12/2/2009)... -- Reportlinker.com announces that a new market r..., Antibiotic Resistance and Antibiotic Technologi....com/p0166825/Antibiotic-Resistance-and-Antibiotic...n in-depth review of the global market for antibio... Offer an analysis of antibiotics resistance from ...

[0] Lombardi's Shields leads special journal focused on tobacco research [1] Hennepin Regional Poison Center Designated as an Accredited Poison Control Center [1] Reportlinker Adds Renal Disease Treatments: Products and Therapies [0] Reportlinker Adds Point of Care Diagnostics [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets

...nt registration of births by 2010 by amending the ...d simplify the process, an official said Friday. ...as this helps in maintaining a record for a person...," D.K. Sikri, Registrar General and Census Commis...

...nt registration of births by 2010 by amending the ...ld simplify the process, an official said Friday. ...as this helps in maintaining a record for a person...,' D.K. Sikri, Registrar General and Census Commis...

... sphere in the US they would like to leave untouch... the cooked chickens market. The U.S. Departm...seeking to familiarize the U.S. market with its co...napproved pesticides or giving antibiotics to live...

...ression of motor disorders: stiffness, slowness, t...l known is that Parkinson's shares other symptoms...y sudden and uncontrollable episodes of deep sleep...something in common: Parkinson's disease patients ...

...to improve healthcare for state prisoners has rele...ction. According to Sillen the 50-page plan "... in prison and protect California communities from...m was so broken that it experienced an average of ...

...in Nova Scotia and now spreading in Ontario. Accor...st affected. The latest outbreak of five peop...tia has put health officials in top alert. Pu... getting infected once more. Ontario's Minis...

Other Medicine News:Health News:Government to Amend Birth Registration Act 2 Health News:Government to Amend Birth Registration Act 2 Health News:China Eyeing US Cooked Chickens Market 2 Health News:UCLA Researchers Discover Link Between Parkinsons and Narcolepsy 2 Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2 Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3 Health News:Mumps Breaks Out In Canada 2

Government to Amend Birth Registration Act Government to Amend Birth Registration Act China Eyeing US Cooked Chickens Market UCLA Researchers Discover Link Between Parkinsons and Narcolepsy Brickbats And Bouquets For U.S Prison Healthcare In-Charge Mumps Breaks Out In Canada

Neuro-Cool™ Cool Head Wrap

ImmunoWELL Mycoplasma pneumoniae Antibody (IgM) Test

...ELL Mycoplasma Pneumoniae Antibody (IgG) Test is a... detection of clinically significant IgG antibodie...human serum specimens. The test should not be used...plasma Pneumoniae Antibody (IgM) Test and is not i...

ImmunoWELL Mumps Virus IgG Test

Medicine Products:

Neuro-Cool™ Cool Head Wrap ImmunoWELL Mycoplasma pneumoniae Antibody (IgM) Test ImmunoWELL Mycoplasma pneumoniae Antibody (IgG) Test ImmunoWELL Mumps Virus IgG Test

ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatien...(ether in this manner. Thorough ...),Health